Literature DB >> 3162507

Chronic pancreatitis, HLA and autoimmunity.

R J Anderson1, P A Dyer, D Donnai, P T Klouda, R Jennison, J M Braganza.   

Abstract

HLA-A and B antigens were studied in 88 Caucasoids with chronic pancreatitis resident in the Manchester area. In the subgroup of 52 patients with alcohol-related chronic pancreatitis HLA-B21 was significantly increased in frequency compared with 344 local controls (Pc = 0.0128). In the non-alcoholic sub-group of 36 patients, the incidence of HLA-A1 was significantly higher than in controls (Pc = 0.0021); whilst HLA-B8 was present in 38.8% of patients and 27.9% of controls. When these data are amalgamated with data from Lyon (France), the antigen HLA-A1 is significantly associated with non-alcoholic chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162507     DOI: 10.1007/BF02788226

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  17 in total

1.  Altered liver histology in patients with pancreatitis: a clue to etiology?

Authors:  N Y Haboubi; H H Ali; J M Braganza
Journal:  Mt Sinai J Med       Date:  1986-05

2.  Chronic pancreatitis and inflammatory bowel disease.

Authors:  A T Axon; M G Ashton; D J Lintott
Journal:  Clin Radiol       Date:  1979-03       Impact factor: 2.350

3.  HLA antigens in chronic alcoholic pancreatitis.

Authors:  R Fauchet; B Genetet; M Gosselin; J Gastard
Journal:  Tissue Antigens       Date:  1979-02

4.  Primary sclerosing cholangitis: findings on cholangiography and pancreatography.

Authors:  R L MacCarty; N F LaRusso; R H Wiesner; J Ludwig
Journal:  Radiology       Date:  1983-10       Impact factor: 11.105

5.  Alcohol-related liver disease: clinical aspects and management.

Authors:  S Sherlock
Journal:  Br Med Bull       Date:  1982-01       Impact factor: 4.291

6.  [Chronic pancreatitis. Connection with HLA antigens].

Authors:  H Betuel; M Selman; A Vachon
Journal:  Nouv Presse Med       Date:  1980-01-05

7.  The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  O Epstein; R W Chapman; G Lake-Bakaar; A Y Foo; S B Rosalki; S Sherlock
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

8.  HLA-B13 and chronic calcific pancreatitis.

Authors:  L Gullo; P L Tabacchi; G R Corazza; F Calanca; O Campione; G Labò
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

9.  HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.

Authors:  E Schrumpf; O Fausa; O Førre; J H Dobloug; S Ritland; E Thorsby
Journal:  Scand J Gastroenterol       Date:  1982-03       Impact factor: 2.423

10.  Ulcerative colitis and persistent liver dysfunction.

Authors:  H A Shepherd; W S Selby; R W Chapman; D Nolan; C Barbatis; J O McGee; D P Jewell
Journal:  Q J Med       Date:  1983
View more
  5 in total

Review 1.  Acute recurrent pancreatitis: an autoimmune disease?

Authors:  Raffaele Pezzilli
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

2.  Sclerosing cholangitis with hepatic microvesicular steatosis in cystic fibrosis and chronic pancreatitis.

Authors:  I Benett; B Salh; N Y Haboubi; J M Braganza
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis.

Authors:  W M Howell; P J Pead; F W Shek; M J Rose-Zerilli; T Armstrong; C D Johnson; D R Fine; J P Iredale; A C Bateman
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

4.  Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism.

Authors:  H Kanno; M Nose; J Itoh; Y Taniguchi; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 5.  Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis.

Authors:  Rakesh Bhatia; Christopher Thompson; Koelina Ganguly; Shailender Singh; Surinder K Batra; Sushil Kumar
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.